A literature-based approach for curating gene signatures in multifaceted diseases.


Journal

Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741

Informations de publication

Date de publication:
10 07 2020
Historique:
received: 16 02 2020
accepted: 05 06 2020
entrez: 12 7 2020
pubmed: 12 7 2020
medline: 15 5 2021
Statut: epublish

Résumé

The task of identifying a representative and yet manageable target gene list for assessing the pathogenesis of complicated and multifaceted diseases is challenging. Using Inflammatory Bowel Disease (IBD) as an example, we conceived a bioinformatic approach to identify novel genes associated with the various disease subtypes, in combination with known clinical control genes. From the available literature, we used Acumenta Literature Lab We generated six relevant gene lists and 21 intersections that contain genes with unique literature associations to Crohn's Disease (n = 60), Ulcerative Colitis (n = 17), and unclassified (n = 45) subtypes of IBD. From this gene pool, we then filtered and constructed, using network analysis, a final list of 142 genes that are the most representative of the disease and its subtypes. In this paper, we present the bioinformatic construction of a gene panel that putatively contains subtype signatures of IBD, a multifactorial disease. These gene signatures will be tested as biomarkers to classify patients with IBD, which has been a clinically challenging task. Such approach to diagnose and monitor complicated disease pathogenesis is a stepping-stone towards personalized care.

Sections du résumé

BACKGROUND AND AIMS
The task of identifying a representative and yet manageable target gene list for assessing the pathogenesis of complicated and multifaceted diseases is challenging. Using Inflammatory Bowel Disease (IBD) as an example, we conceived a bioinformatic approach to identify novel genes associated with the various disease subtypes, in combination with known clinical control genes.
METHODS
From the available literature, we used Acumenta Literature Lab
RESULTS
We generated six relevant gene lists and 21 intersections that contain genes with unique literature associations to Crohn's Disease (n = 60), Ulcerative Colitis (n = 17), and unclassified (n = 45) subtypes of IBD. From this gene pool, we then filtered and constructed, using network analysis, a final list of 142 genes that are the most representative of the disease and its subtypes.
CONCLUSIONS
In this paper, we present the bioinformatic construction of a gene panel that putatively contains subtype signatures of IBD, a multifactorial disease. These gene signatures will be tested as biomarkers to classify patients with IBD, which has been a clinically challenging task. Such approach to diagnose and monitor complicated disease pathogenesis is a stepping-stone towards personalized care.

Identifiants

pubmed: 32650786
doi: 10.1186/s12967-020-02408-7
pii: 10.1186/s12967-020-02408-7
pmc: PMC7350750
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

279

Références

Nat Rev Gastroenterol Hepatol. 2009 Apr;6(4):228-35
pubmed: 19347014
Curr Gastroenterol Rep. 2010 Aug;12(4):249-58
pubmed: 20532706
Nature. 2014 Apr 17;508(7496):312-3
pubmed: 24745070
Semin Pediatr Surg. 2017 Dec;26(6):349-355
pubmed: 29126502
Cell Immunol. 2017 Feb;312:35-41
pubmed: 27889082
J Gastroenterol. 2003;38(7):647-55
pubmed: 12898357
World J Gastroenterol. 2015 Jan 7;21(1):21-46
pubmed: 25574078
World J Gastroenterol. 2008 Oct 14;14(38):5834-41
pubmed: 18855982
BMC Genomics. 2007 Dec 18;8:461
pubmed: 18088408
Histopathology. 2014 Feb;64(3):317-35
pubmed: 24266813
World J Gastrointest Endosc. 2017 Jan 16;9(1):34-40
pubmed: 28101306
Inflamm Bowel Dis. 2016 May;22(5):1184-97
pubmed: 26717320
Curr Opin Gastroenterol. 2013 Jul;29(4):378-83
pubmed: 23624676
Innate Immun. 2017 Aug;23(6):497-505
pubmed: 28770665
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W214-20
pubmed: 20576703
PLoS One. 2018 Nov 27;13(11):e0208037
pubmed: 30481204
J Transl Med. 2019 Dec 13;17(1):419
pubmed: 31836022
J Proteome Res. 2012 Oct 5;11(10):4916-26
pubmed: 22957933
Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):720-7
pubmed: 26323879
J Pediatr Gastroenterol Nutr. 2014 Jun;58(6):795-806
pubmed: 24231644
Cell Mol Gastroenterol Hepatol. 2019;7(2):357-369
pubmed: 30704984
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243

Auteurs

Mathieu Garand (M)

Research Department, Sidra Medicine, Doha, Qatar. mathieu.garand@gmail.com.

Manoj Kumar (M)

Research Department, Sidra Medicine, Doha, Qatar.

Susie Shih Yin Huang (SSY)

Research Department, Sidra Medicine, Doha, Qatar.

Souhaila Al Khodor (S)

Research Department, Sidra Medicine, Doha, Qatar. salkhodor@sidra.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH